Page last updated: 2024-12-08

da 5018

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

DA 5018: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID177286
MeSH IDM0266866

Synonyms (16)

Synonym
da-5018
capsavanil
benzeneacetamide, 4-(2-aminoethoxy)-n-(3-(3,4-dimethylphenyl)propyl)-3-methoxy-, monohydrochloride
da 5018
n-(3-(3,4-dimethylphenyl)propyl)-4-(2-aminoethoxy)-3-methoxyphenyl acetamide
davasaicin hydrochloride
unii-51v6n8ba2p
51v6n8ba2p ,
174661-97-3
benzeneacetamide, 4-(2-aminoethoxy)-n-(3-(3,4-dimethylphenyl)propyl)-3-methoxy-, hydrochloride (1:1)
DTXSID40169887
Q27260923
2-(4-(2-aminoethoxy)-3-methoxyphenyl)-n-(3-(3,4-dimethylphenyl)propyl)acetamide hydrochloride
2-[4-(2-aminoethoxy)-3-methoxyphenyl]-n-[3-(3,4-dimethylphenyl)propyl]acetamide;hydrochloride
benzeneacetamide, 4-(2-aminoethoxy)-n-[3-(3,4-dimethylphenyl)propyl]-3-methoxy-, hydrochloride (1:1)
AKOS040745705

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" administration of DA-5018, 1, 2, and 5 mg kg-1, the pharmacokinetic parameters of DA-5018 were independent of the dose ranges studied."( Pharmacokinetics of a non-narcotic analgesic, DA-5018, in rats.
Kim, SH; Kim, WB; Lee, JJ; Lee, MG; Lee, SD; Shim, HJ; Yang, J, 1998
)
0.3

Bioavailability

ExcerptReferenceRelevance
" After oral administration of DA-5018, absorption of the drug from gastrointestinal (GI) tract was fast, but the extent of absolute bioavailability (F) was low; the values were 23."( Pharmacokinetics of a non-narcotic analgesic, DA-5018, in rats.
Kim, SH; Kim, WB; Lee, JJ; Lee, MG; Lee, SD; Shim, HJ; Yang, J, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.93 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index23.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]